European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
Subscribe To Our Newsletter & Stay Updated
